DISICIDE
DEAD
Serial Number
79302241
Owner
Terapima Sweden AB ORG.NR. SE556547992901Attorney
Abraham LichyFiling Date
Jun 1, 2020
DISICIDE Trademark
Serial Number: 79302241
DISICIDE is a trademark filed by
Terapima Sweden AB ORG.NR. SE556547992901
on June 1, 2020. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently no longer active.
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
June 1, 2020
Registration Date
Not Registered
Goods & Services
Disinfectants; disinfectants for household use; disinfectants for hygienic purposes on surfaces; disinfectants for personal hygiene; disinfection wipes; disposable sanitizing wipes impregnated with disinfectants
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 25, 2022 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Oct 6, 2022 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 6, 2022 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 4, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 15, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 15, 2022 OPNR
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Oct 6, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 6, 2021 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 25, 2021 GNRN
NON-FINAL ACTION E-MAILED
Mar 25, 2021 GNRT
NON-FINAL ACTION WRITTEN
Mar 25, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 19, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 19, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 19, 2021 TROA
REFUSAL PROCESSED BY IB
Mar 1, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 7, 2021 RFCS
REFUSAL PROCESSED BY MPU
Feb 7, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 24, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jan 23, 2021 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 19, 2021 MAFR
ASSIGNED TO EXAMINER
Jan 15, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 15, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 14, 2021 REPR
